DOI: 10.12890/2026_006682
Hospital-acquired Kluyvera georgiana bacteremia in a patient with decompensated cirrhosis: a case report from Vietnam and a literature review
Authors
nguyenlienha@hmu.edu.vn
Keywords
Bacteraemia, liver cirrhosis, cirrhosis-associated immune dysfunction (CAID), MALDI-TOF MS, hospital-acquired infectionAbstract
Bacteraemia caused by Kluyvera georgiana is an exceedingly rare clinical entity. As of 2024, only one case had been reported in the world literature: a 67-year-old female patient with recurrent pancreatic cancer undergoing chemotherapy in Japan, in whom the portal of entry for the pathogen was the biliary tract following choledochojejunotomy. We report the second case worldwide and the first from Vietnam, occurring in a 34-year-old male with decompensated cryptogenic cirrhosis. On hospital day 10, the patient developed high-grade fever (39.5°C) with rigors. Two independent blood culture sets drawn from two separate peripheral venous sites both yielded K. georgiana, identified by matrix-assisted laser desorption/ionization time of flight mass spectrometry. Notably, the patient exhibited leukopenia (1.710 cells/microlitres) with only minimally elevated procalcitonin (0.08 ng/ml), reflecting a blunted inflammatory response characteristic of cirrhosis-associated immune dysfunction. Antimicrobial susceptibility testing demonstrated resistance to ampicillin-sulbactam, ciprofloxacin, cefotaxime, ceftazidime, and trimethoprim-sulfamethoxazole, a substantially broader resistance phenotype than reported in the first case. The patient was treated with intravenous imipenem/cilastatin for 14 days and achieved complete clinical recovery. This case expands the recognized at-risk population for K. georgiana bacteraemia to include patients with decompensated cirrhosis, underscores the critical diagnostic value of early blood cultures when inflammatory markers are unreliable, and highlights the necessity of comprehensive antimicrobial susceptibility testing given the potentially variable resistance phenotypes among K. georgiana strains.
References
- Sarria JC, Vidal AM, Kimbrough III RC. Infections caused by Kluyvera species in humans. Clin Infect Dis 2001;33:e69-e74. doi: 10.1086/322686
- Pavan ME, Franco RJ, Rodriguez JM, Gadaleta P, Abbott SL, Janda JM, et al. Phylogenetic relationships of the genus Kluyvera: transfer of Enterobacter intermedius Izard et al. 1980 to the genus Kluyvera as Kluyvera intermedia comb. nov. and reclassification of Kluyvera cochleae as a later synonym of K. intermedia. Int J Syst Evol Microbiol 2005;55:437-442. doi: 10.1099/ijs.0.63071-0
- Endo G, Kanai S, Nishio H, Hashimoto H, Higurashi Y, Nomura Y, et al. Kluyvera Georgiana bacteremia due to acute cholangitis: a report of the first known case and a literature review. Intern Med 2024;63:2689-93. doi: 10.2169/internalmedicine.3036-23
- Cantón R, González-Alba JM, Galán JC. CTX-M enzymes: origin and diffusion. Front Microbiol 2012;3:110. doi: 10.3389/fmicb.2012.00110
- Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol 2016;8:307. doi: 10.4254/wjh.v8.i6.307
- Hasa E, Hartmann P, Schnabl B. Liver cirrhosis and immune dysfunction. Int Immunol 2022;34:455-66. doi: 10.1093/intimm/dxac030
- Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. Beta-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 2002;46:3045-3049. doi: 10.1128/aac.46.9.3045-3049.2002
- Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem 2015;61:100-111. doi: 10.1373/clinchem.2014.221770
